HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mathew Garnett Selected Research

Mathew Garnett Research Topics

Disease

9Neoplasms (Cancer)
01/2022 - 11/2005
1Breast Neoplasms (Breast Cancer)
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Necrosis
01/2018
1Malignant Mesothelioma
01/2018
1Carcinogenesis
02/2017
1Melanoma (Melanoma, Malignant)
01/2015
1Colonic Neoplasms (Colon Cancer)
11/2012
1Lung Neoplasms (Lung Cancer)
11/2012

Drug/Important Bio-Agent (IBA)

3Phosphotransferases (Kinase)IBA
02/2013 - 11/2005
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
02/2013 - 11/2012
1Caspase 8 (Caspase-8)IBA
01/2022
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
01/2022
1Drug CombinationsIBA
01/2020
1BMS 754807IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Insulin ReceptorIBA
01/2020
1dabrafenibIBA
01/2020
1Deubiquitinating EnzymesIBA
01/2018
1LigandsIBA
01/2018
1Death Domain ReceptorsIBA
01/2018
1Odorant Receptors (Odorant Receptor)IBA
02/2017
1trametinibIBA
01/2015
1VS-5584IBA
02/2013
1Mechanistic Target of Rapamycin Complex 1IBA
02/2013
1Mediator ComplexIBA
11/2012
1Tyrosine (L-Tyrosine)FDA Link
11/2012
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2012
1Gefitinib (Iressa)FDA Link
11/2012
1Protein Isoforms (Isoforms)IBA
11/2005
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
11/2005

Therapy/Procedure

3Therapeutics
01/2017 - 01/2013
2Drug Therapy (Chemotherapy)
01/2018 - 11/2012